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Abstract.  P30 is a heparin-binding  protein with adhe- 
sive and neurite outgrowth-promoting properties pres- 
ent at high levels in the developing rat central nervous 
system (Rauvala, H., and R. Pihlaskari.  1987 J.  Biol. 
Chem.  262:16625-16635).  Partial  sequencing of p30 
has revealed homology or identity with HMG-1 (Rau- 
vala,  H., J.  Merenmies,  R. Pihlaskari,  M.  Korkolai- 
hen,  M.-L.  Huhtala,  and P. Panula.  1988. J.  Cell 
Biol.  107:2292-2305),  a 28-kD protein that was origi- 
nally purified from the thymus (Goodwin, G.  H., C. 
Sanders,  and E. W. Johns.  1973.  Eur.  J.  Biochem. 
38:14-19) which binds DNA in vitro. We have ana- 
lyzed the distribution of p30 in the developing rat pe- 
ripheral  nervous system (PNS).  P30 was detected by 
immunohistochemistry  and Western blot analysis using 
antibodies raised against intact p30 and against a  syn- 
thetic peptide corresponding to the amino terminus of 
the p30 molecule. 
P30 was localized to nonnuclear compartments of 
neurons and peripheral glial cells (Schwann cells). 
P30 immunoreactivity of PNS neurons persisted into 
adulthood.  In contrast,  Schwann cell staining de- 
creased after the second postnatal week and was not 
detectable in adult animals. 
Neuron-Schwann cell contact was correlated with 
diminished p30 levels in Schwann cells.  Schwann cells 
of the normal adult sciatic nerve did not express p30; 
however, when deprived of axonal contact by nerve 
transection,  the Schwann cells of the distal nerve 
stained intensely for p30. In addition,  when Schwann 
cells and dorsal root ganglion neurons were grown in 
coculture,  Schwann cells that were associated with 
neurites were not as intensely stained by anti-p30 as 
Schwann cells that were not in contact with neurons. 
The pattern of p30 expression during development 
and regeneration,  and its apparent regulation by cell- 
cell contact suggests that p30 plays a role in the inter- 
action between neurons and Schwann cells during 
morphogenesis of peripheral  nerves. 
T 
HE  development  of the  peripheral  nervous  system 
(PNS) 1  provides a good example of the importance of 
cell-cell interactions  in morphogenesis.  A large body 
of work has  demonstrated  the developmental  interdepen- 
dence of neurons and Schwann cells, the major cellular com- 
ponents of the PNS. Schwann cells adhere to neurons (Salzer 
and Bunge,  1980;  Sobue and Pleasure,  1985) and contact 
with  axons  stimulates  Schwann  cells to proliferate  (Wood 
and Bunge,  1975; Salzer et al.,  1980; Ratner et al.,  1987), 
to produce basal lamina  components (Bunge  et al.  1982, 
Clark and Bunge,  1989), and to form myelin (Weinberg and 
Spencer,  1975). Schwann cells in turn may affect developing 
neurons.  Schwann cells promote axonal outgrowth  (Fallon, 
1985; Rickmann and Fawcett,  1985; Tomaselli et al., 1986) 
and may be involved in guiding  axons to their appropriate 
targets (Yntema, 1943; Noakes and Bennet,  1987; Noakes et 
al.,  1988). 
1. Abbreviations  used in this paper:  CNS, central nervous system; DRG, 
dorsal root ganglia; PNS, peripheral nervous system. 
Defined adhesive molecules have been implicated  in cer- 
tain of these neuron-Schwann cell interactions.  For exam- 
ple,  antibodies  that  recognize  Ng-CAM  (L1, NILE)  can 
block  ensheathment  of  axons  and  myelin  formation  by 
Schwann cells in vitro (Seilheimer  et al., 1989; Wood et al., 
1990). In addition,  a combination of antibodies against Ng- 
CAM, N-cadherin,  and integrin,  can almost entirely block 
neurite outgrowth  on Schwann cell surfaces (Bixby et al., 
1988; Seilheimer  and Schachner,  1988). It is not yet known 
how many adhesive molecules contribute to peripheral nerve 
morphogenesis.  There is evidence that as yet undefined mol- 
ecules contribute to some aspects  of peripheral  nerve de- 
velopment.  For example, the initial event in the interactions 
between neurons and Schwann cells is the cell-specific  rec- 
ognition and adhesion between neurons and Schwann cells; 
this  initial cell adhesion  is not inhibited  by antibodies that 
have been tested against known adhesion  molecules (Bixby 
et al.,  1988; Landmesser et al.,  1988). 
P30 was recently described as a protein that is abundant 
in neonatal  rat brains and present at lower levels  in adult 
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growth promoting activity for embryonic rat brain cells and 
N18  neuroblastoma cells (Rauvala  and Pihlaskari,  1987). 
Because p30 is present in the central nervous system (CNS), 
is regulated during development, has adhesive activity, and 
can promote neurite outgrowth, it was important to deter- 
mine whether p30 is present in the PNS. 
P30 has also been called arnphoterin, since the carboxy 
terminal is highly negatively charged while the amino termi- 
nus contains eight of thirteen positively charged residues 
(Rauvala,  1989).  The amino-terminal thirteen amino acids 
of  this 30,000-D protein have been sequenced. This sequence 
has no homology to known adhesive proteins (Rauvala et al., 
1988),  but  is  identical  to  the  NH2-terminal  sequence  of 
HMG-1 (Bustin et al., 1990),  a 28,000-D protein expressed 
in many tissues including  brain, suggesting that these proteins 
are related or identical. In this manuscript we use the name 
p30, as the work on p30 was the first indication of the poten- 
tial importance of this protein in the development of the ner- 
vous system.  HMG-1  was initially described as a  nuclear 
protein associated with ehromatin (Goodwin et al.,  1973), 
but it has been localized outside of the nucleus in a number 
of tissue types (Bustin  and Niehart,  1979;  Teng and Teng, 
1981; Mosevitsky et al.,  1989).  The function of HMG-1  is 
unknown. 
The availability of the amino-terminal sequence of p30, 
(Rauvala et al., 1988), enabled us to produce an antipeptide 
antibody to examine the distribution of p30 in the PNS. In 
this study we have shown that p30 is expressed in the PNS 
and that its pattern of expression is altered during develop- 
ment and nerve regeneration. P30 is present in both neurons 
and Schwann cells during early postnatal development, but 
is not present in Schwann ceils of  the adult. After nerve tran- 
section, p30 is upregulated in Schwann cells. A tissue culture 
system (Wood  and Bunge,  1975, Ratner et al.,  1986)  was 
used to study neuron-Sehwann cell interactions in the ab- 
sence of other cells. With this model we were able to demon- 
strate that p30 expression in Schwann cells is modulated by 
contact with neurons. The pattern of expression of p30 dur- 
ing development and regeneration and its regulation by cell- 
cell contact in vitro suggest that this molecule plays a role 
in the interactions between neurons and Schwann cells that 
occur during development. 
Materials and Methods 
Isolation of P30 
P30 was prepared as described in Rauvala  and Pihlaskari (1987).  Briefly, 
octyl glucoside-solubilized proteins from P8 rat brain membranes were 
loaded onto a heparin-Sepharose column (Pharmacia Fine Chemicals, Pis- 
caraway, NJ) and elnted using a 0-3 M NaC1 gradient. The fractions that 
contained p30 were determined by ELISA. 50/~1 from each fraction were 
added to individual wells. Anti-p30 peptide (10 #g/ml) was used as the 
probe to identify p30 containing fractions, which were pooled and purified 
further by Affi-Gel blue (Bio-Rad, Rockville Ctr., NY) chromatography. 
P30 accounted for ,,090% of  the total protein that elnted from Affi-Gel blue 
at  1.5 M  NaCI. 
Antibodies 
The antibody against $100 was a polyclonal antibovine SI00 (Dako Corp., 
Santa Barbara, CA). The mAb 217c was a gift from Jean De Vellis (UCLA). 
An mAb recognizing the 160-kD neurofilament polypeptide was purchased 
from Boehringer Mannheim Biochemicals (Indianapolis, IN). 
Polyclonal antibodies were generated against a peptide, representing the 
14 NH2-terminal amino acids of p30. The anti-p30 peptide antibodies were 
prepared as described in Rauvala et al. (1988).  Briefly, the peptide was cou- 
pled to keyhole limpet hemocyanin (Liu et al., 1979) and injected into rab- 
bits (0.3 mg peptide/rabbit/injection). The antibody was purified from se- 
rum by affinity chromatography using the synthetic peptide coupled to 
EAH-Sepharose (Pharmacia Fine Chemicals) (Rauvala  et al.,  1988). 
Polyclonal antibodies were also generated against intact p30, purified as 
described above.  Affi-gel blue-purifiefl p30 was further purified by non- 
reducing 12.5 % SDS-PAGE. One lane from the gel was stained by Coomas- 
sie blue to locate the region of the gel containing p30. The p30-containing 
regions of the gel were cut out and the gel slabs were homogenized in PBS 
and mixed with Freund's adjuvant (Difco Laboratories, Detroit, MI) for in- 
jection into rabbits (60 #g protein/rabbit/injection). 
For immunization against both the peptide and intact p30, primary injec- 
tions were in complete Freund's adjuvant,  and subsequent injections (at 
3-wk intervals) were in incomplete Freund's adjuvant. 
Immunostaining of gissue Sections and Cultured Cells 
Rat pups at postnatal days 1, 3, 5, 8, 9, 11, 15, 42 and adult rats were killed 
by an overdose of sodium pantobarbital (Anthony Products Co., Arcadia, 
CA) and then fixed by perfusion with 4% paraformaldehyde in 0.1 M Na 
phosphate buffer, pH 7.4. Embryos at days 15 and 18 of gestation were dis- 
sected to expose the spinal cord then fixed by immersion for 20 h at 4°C 
in the same fixative that was used for perfusion. After fixation, the spinal 
cords with attached dorsal root ganglia (DRG) and the sciatic nerves were 
dissected out and placed in 20%  sucrose until the tissue was completely 
infiltrated (usually overnight). The tissue was then embedded in Tissue-Tek 
O.C.T. compound (American Scientific Products Div., McGaw Park, IL), 
frozen in liquid nitrogen-cooled isopentane, and then sectioned at 10 #m 
on a cryostat (Leitz, 1720 Digital). Tissue was stored at -80°C for up to 
3 mo after freezing and before sectioning. 
Tissue sections were mounted on glass slides, allowed to dry at room 
temperature for  10 min,  then placed in 2%  normal goat serum (Gibeo 
Laboratories, Grand Island, NY) in PBS, pH 7.4.  They were then treated 
with  the  antibodies;  anti-p30  peptide  (10  t~g/ml),  anti-p30  (antiserum 
1:4,500),  $100  (1:1,000),  217c (1:100) or neurofilament (1:1,000) followed 
by biotinylated goat antirabbit or goat antimouse (Vector Laboratories, 
Budingame,  CA).  Avidin-biotin peroxidase visualization was  then per- 
formed using the Vecta-stain Elite kit (Vector Laboratories). In some ex- 
periments fiuorescenfly labeled secondary antibodies (goat antirabbit FITC 
and goat antimouse rhodamine; Kirkegaard-Perry, Gaithersburg, MD) were 
used to visualize immunoreactivity. 
Cultured cells to be stained were grown on 12-mm round glass coverslips 
(Bellco, Vineland, NJ). The cells were fixed in 4% paraformaldehyde or 
methanol at -20°C and treated with 10% normal goat serum in Leibovitz's 
L-15 medium (Gibco Laboratories), then with anti-p30 peptide diluted to 
10 #g/ml in the same medium. The coverslips were then treated for peroxi- 
dase visualization using the Vecta-stain Elite kit (Vector Laboratories), 
dried, and inverted on glass slides in DPX mounting medium. 
For negative controls, anti-p30 peptide was preabsorbed by diluting the 
antibody to 10 t~g/ml in PBS containing 100 #g/ml synthetic peptide. The 
antibody was incubated with the peptide at room temperature for 1 h. Nor- 
mal goat serum was then added and the preabsorbed antibody was applied 
to tissue sections or cultured cells. 
Cell Culture 
Neurons were prepared from embryonic day  15 rat DRG as described in 
Rather et al. (1985).  Schwann cells were prepared from sciatic nerves of 
perinatal rats by the method of Brockes et al. (1979) with modifications as 
described in Ratner et al. (1986). 
Nerve Transection 
Adult rats were anaesthetized by ether. The sciatic nerve was exposed by 
separating the muscles of  the upper hindiimb. The nerve was transected  just 
distal to the sciatic notch and the proximal and distal ends were sewn to- 
gether, with cut ends abutting, with a suture. After 2 wk the animals were 
killed by an overdose of sodium pontobarbital (Anthony Products Co.), per- 
fused with 4 % paraformaldehyde and prepared for immunohistochemistry. 
Preparation of CeU and Tissue Extracts 
DRG neurons were grown on 35-ram plastic tissue culture dishes coated 
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antibody recognizes a  30-kD 
brain protein.  Octyl-glucoside- 
solubilized brain  membranes 
from P8 rats were eluted from 
a  heparin-Sepharose  affinity 
column with a NaC1 gradient. 
A p30-containing fraction (de- 
termined by ELISA) was sepa- 
rated by reducing SDS-PAGE 
(10/zg protein/lane) and trans- 
ferred  to  nitrocellulose  for 
Western  blot  analysis.  (A) 
The gel was stained with Coo- 
massie  blue  atter  transfer  to 
nitrocellulose to show the total 
protein  composition  of  the 
heparin-eluted  brain  extract. 
The  nitrocellulose  was  incu- 
bated with (B) 10/zg/ml anti- 
p30 peptide or (C)  10 ~g/ml 
anti-p30 peptide with 100 #g/ml peptide. Bio-Rad SDS- PAGE low 
molecular weight standards were used. The anti-p30 peptide anti- 
body is specific for a  heparin-binding protein of ,~ 30 kD Mr in 
young rat brains.  Immunoreactivity is abolished by incubation of 
the  antibody with  the  synthetic  peptide that  corresponds  to the 
NH2-terminal  amino  acid  sequence  of p30  (Rauvala  and  Pih- 
laskari,  1988). 
with rat tail collagen (Rather et al.,  1985). The collagen layer containing 
the cells was scraped up using a plastic pipette tip, then homogenized by 
50 strokes in a glass-glass dounce homogenizer in homogenization buffer 
(HB, 0.16 M sucrose, 1 mM MgC12 in 10 mM "Iris, pH 7.4) with protease 
inhibitors (100/~g/ml PMSF, 100/~g/ml NEM, and 5 mM EDTA) at 1 rrd 
per "o350 gangfia. The extract was then spun at 2,000 RPM in a clinical 
centrifuge (Hennle) to remove nuclei and collagen. 
Schwann cells grown on  tissue  culture plastic  were suspended in 
Leibovitz's L-15 medium (Gibco Laboratories) by scraping with a rubber 
policeman. The ceils were pelleted and then extracted in  150 /~l/3×t06 
cells PBS with 1% Triton and 0.1% SDS (with protease inhibitors as in HB) 
for 5 rain on ice. The extract was then spun in a microcentrifuge (Allied- 
Fisher model 253-C) for 2 rain to remove nuclei. 
Tissue samples from P9 and adult rats, or whole El0 or El2 embryos, 
were minced with a razor blade, then homogenized  in a glass-glass dounce 
homogenizer in HB with protease inhihitors (1 mi/100 mg tissue). The ex- 
tract was then centrifuged  (as in DRG neuron extract preparation)  to remove 
nuclei. 
Protein concentrations of the cell and tissue extracts were determined 
using the Bio-Rad protein assay. 
Western Blots 
Extracts  were solubilized and  proteins  separated by  12%  SDS-PAGE 
(Laemmli, 1970; Bio-Rad  Protean 1I slab cell) and transferred  to nitrocellu- 
lose  using the  Novablot transfer  apparatus  (LKB Instruments,  Inc., 
Gaithersburg, MD). The nitrocellulose was then treated with antibodies and 
processed for alkaline phosphatase visualization (Blake et al.,  1984). 
Results 
Characterization of  Antibodies Recognizing P30 
An  antibody  generated  against  a  synthetic  peptide  corre- 
sponding  to  the  NH2-terminal  sequence  of p30  (anti-p30 
peptide)  recognized  a  30-kD  protein  in  Western  blots  of 
heparin-purified  brain extracts,  as described  by Rauvala et 
al.  (1988).  Incubation of the antibody with a  10-fold excess 
(wt/wt)  of peptide  abolished  reactivity  on  Western  blots, 
demonstrating that the antibody was specific for the amino- 
terminal  domain of authentic  p30  (Fig.  1). 
Tissue Distribution of P30 
P30 is not specific to the developing nervous system. When 
entire rat embryos (El0,  El2) were sectioned and immuno- 
stained using  the anti-p30  peptide  antibody,  all,  or almost 
all,  cells  of the developing embryo were labeled.  Fig.  2  a 
shows an example of an El2  spinal cord,  with  surrounding 
mesenchyme and DRG, demonstrating the broad distribution 
of p30 early in development. Immunostaining was greatly di- 
minished by preabsorption of the antibody with the p30 pep- 
tide (Fig.  2 b). To confirm that embryonic staining was due 
to expression of p30,  crude extracts of whole El2  embryos 
were analyzed using Western blots. A  band of immunoreac- 
tivity was observed that comigrated with authentic brain p30. 
Immunoreactivity was abolished  by incubation  of the anti- 
body with the p30 peptide (Fig. 2 c). In addition, pc) rat pups 
contained p30, as analyzed by Western blot, in all organs ex- 
amined (adrenal gland,  kidney,  liver,  spleen heart,  skeletal 
muscle, sciatic nerve, and brain) (not shown). A wide distri- 
bution is consistent with the findings of Rauvala (1989), who 
found that p30 was present in extracts of P14 rat heart, liver, 
skeletal muscle,  brain,  and kidney. 
P30 Expression during PNS Developm~t 
The distribution  of p30 within the nervous system changed 
during early development. DRG and dorsal roots were exam- 
ined in detail to determine the developmental pattern of ex- 
pression of p30 in the PNS.  Cryostat sections of spinal cord 
from the thoracic  region,  with  attached  DRG,  were taken 
from rats  of various  ages ranging  from embryonic day  10 
(El0)  through  adulthood.  While  at El2  p30  immunoreac- 
tivity was present in what appeared to be all cells of the de- 
veloping  spinal  cord,  DRG  and  surrounding  mesenchyme 
(Fig.  2), postnatally p30 was expressed in only a  subset of 
neurons and glia within the spinal cord (Daston, M. M., and 
N.  Ratner.  1990.  Soc. Neurosci.  Abstr.  16:352).  In the de- 
veloping PNS, postnatal expression of p30 was restricted to 
neurons  and  Schwann  cells. 
Schwann cell proliferation, sorting of axons into fascicles, 
and myelination of axons by Schwann cells occur during the 
first two to three postnatal  weeks in the rat (Asbury,  1967; 
Webster et al.,  1973);  this is the period in which  Schwann 
cell p30 staining is most intense.  Immunostaining revealed 
Schwann cells among the axons of the dorsal root at postnatal 
day 1 (Fig.  3, a  and b); cell bodies of DRG sensory neurons 
were also labeled.  Schwann cells were consistently  labeled 
by the  antibody  through  postnatal  day  11  (Fig.  3,  c  and d 
shows p30 labeling at P3 which is representative of the pat- 
tern seen at P3-P11),  but no Schwann cell labeling was ob- 
served at P15 (Fig.  3, e and f) or in adult rats (Fig.  3, g  and 
h).  In  contrast,  DRG  neuron  cell  bodies  remained  im- 
munoreactive  into  adulthood.  In addition,  large axons  (or 
axon fascicles) were stained by the antibody in adult rats. In 
young animals, axonal staining was sometimes visible prox- 
imal to the DRG neuron  cell bodies.  This pattern  suggests 
that axons are immunoreactive in younger animals, but that 
low levels of reactivity or the fine caliber of developing axons 
make these processes difficult to visualize. 
Identical staining patterns were observed when the spinal 
cords and DRG from P8 and adult rats were immunostained 
using an antiserum against intact p30 purified  from P8  rat 
brain membranes (not shown). 
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in embryonic spinal cord and 
DRG. Adjacent  10-t~m cryo- 
stat cross  sections of an El2 
embryo  showing the  spinal 
cord,  DR(]  and  surrounding 
mesenchyme  were  immuno- 
stained  using  (A)  10  ~g/ml 
anti-p30 peptide or (B) 10 t~g/ 
ml anti-p30 peptide with  100 
ftg/ml peptide.  All  cells  ap- 
pear to be labeled by the anti- 
p30 peptide antibody and the 
intensity of  immunostaining is 
reduced to background levels 
by preincubation  of the anti- 
body with the  synthetic pep- 
tide corresponding to the NH2- 
terminal sequence of p30. (C) 
The presence of  p30 in a crude 
extract of whole El2 embryos 
(see Materials  and Methods) 
was verified by Western blot 
(28 ~tg protein/lane)  using 10 
/~g/ml anti-p30  peptide  (lane 
1). P30 immunoreactivity was 
specifically abolished by incu- 
bation of  the antibody with the 
synthetic peptide as in Fig. 1 
(lane 2). The band of immu- 
noreactivity  comigrated  with 
authentic  p30  purified  from 
P9  rat  brains  (not  shown). 
Bio-Rad prestained SDS-PAGE 
molecular  weight  standards 
were used.  Bar,  100 ~m. 
Expression of P30 in Cultured Neurons and 
Schwann Cells 
Previous studies have shown that p30 is expressed in brain, 
by dissociated embryonic CNS cells, including neurons, and 
by  a  neuroblastoma  cell  line,  (Rauvala  and  Pihlaskari, 
1988). It was therefore surprising to note the apparent expres- 
sion of p30 by developing nonneuronal cells.  However, the 
interpretation of immunostained cryostat sections of periph- 
eral nerves is complicated by the intimate relationship be- 
tween axons and their sheath ceils. At the light microscope 
level, therefore,  it can be difficult to differentiate between 
staining of axons or Schwann cells. Therefore, to asses syn- 
thesis and expression of p30 in both developing neurons and 
Schwann cells we turned to an in vitro system in which these 
cell  types  can  be  separated  (Wood,  1976;  Ratner  et  al., 
1986).  The results of two kinds of experiments suggest that 
p30 is expressed by both DRG neurons and by Schwann cells. 
First, Western blot analysis of DRG neurons and Schwann 
cells purified in  culture  confirmed the presence of p30 in 
both of these cell types (Fig. 4). Extracts from both neurons 
and Schwann cells showed a band of immunoreactivity that 
comigrated with authentic p30 partially purified from p9 rat 
brains  by heparin-Sepharose affinity  chromatography.  No 
reactivity was observed when the antipeptide antibody was 
preabsorbed with  100 #g/ml peptide.  Significantly greater 
levels of anti-p30 immunoreactivity were detected in Schwann 
cells than in neurons.  In addition,  immunostaining of cul- 
tured DRG neurons and Schwann cells was carried out. Cul- 
tured DRG neurons and Schwann cells stained lightly when 
fixed with paraformaldehyde before immunostaining (Fig. 5, 
a  and c), or when live cells were incubated with antibody, 
washed,  and then fixed with paraformaldehyde.  These re- 
suits suggest that p30 is expressed by both cell types, and that 
p30 is detectable on the cell's surface. 
Cultures of purified Schwann cells and DRG neurons usu- 
ally contained a small number of fibroblasts. The fibroblasts 
were  not  labeled  by  the  anti-p30  peptide  antibody  (not 
shown). 
Figure 3. P30 is expressed in Schwann cells of young animals but not in adults. Schwann cells (solid arrows) labeled by anti-p30 peptide 
(10/zg/ml) can be seen in DRG at P1 (A and B), P3 (C and D), but not at P15 (E and F) or in adult (G and H). B, D, F,, and H are enlargements 
of the encircled areas in A, C, E and G, respectively. Open arrows point to large myelinated axons. Bars: (A, C, E, and G) 50 #m; (B, 
D, F,, and H) 10 gm. 
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ity can be detected  in extracts 
of DRG neurons and Schwann 
cells purified in culture. Crude 
extracts  of DRG neurons and 
Schwarm cells (see Materials 
and Methods) were separated 
by SDS-PAGE and transferred 
to nitrocellulose  for Western 
blot analysis.  A protein with 
the same mobility as authentic 
p30 from P9 rat brain (b) was 
labeled by anti-p30 peptide  in 
Schwann  cell  (sc) and  DRG 
neuron (n) extracts (50/zg pro- 
tein/lane).  Bio-Rad prestained 
SDS-PAGE molecular weight 
standards  were used. 
lntraceUular Expression of  P30 
Several lines of evidence suggest a  significant intracellular 
pool of p30.  The appearance  of labeled  cells  in  immuno- 
stained tissue sections was indicative of an intracellular anti- 
gen. Label was uniform and not confined to the perimeter 
of the cells (Figs. 2, 3, and 6).  When immunostaining cul- 
tured cells, permeabilization using several different reagents 
(methanol, 0.2% Triton-X 100, or 0.1%  saponin) before the 
addition of the anti-p30 peptide antibody always resulted in 
more intense labeling of Schwann cells and neuron cell bod- 
ies as compared to immunostained cells that were not per- 
meabilized.  However,  when  DRG  neurons  and  Schwann 
cells purified in culture were separated into crude membrane 
and cytosolic fractions, p30 was detectable by immunoblot 
in the membrane fractions and not the cytosolic fractions of 
both cell types (data not shown). 
Rauvala et al.  (1988) also found evidence for intracellular 
Figure 5. Antibodies against p30 label cell surface of neurons and Schwarm cells in culture.  DRG neurons and Schwann cells were purified 
in culture separately. DRG neurons (A and B) and Schwann cells (Cand D) were fixed in 4% paraformaidehyde  (10 min, room temperature) 
and immunostained using anti-p30 peptide.  (A and C)), or anti-p30 peptide preabsorbed with the peptide  (B and D). Bar, 20/zm. 
The Journal of Cell Biology, Volume 112, 1991  1234 Figure 6. P30 staining increased in Schwann cells of the distal stump of the transected sciatic nerve.  10-#m cryostat sections of proximal 
stump (A and B ), nerve scar (  C and D ), and distal stump (E and F) of  the transected sciatic nerve were immunostained using anti-p30 peptide 
(A, C, and E)), or anti-S100 (B, D, and F). S100 is a Schwann cell marker. The distribution of p30 and Sl00 is different in the proximal 
stump and similar in the nerve scar and the distal stump, indicating that p30 is present in Sehwann cells distal to, but not proximal to, the 
point of transection.  Bar, 5 #m. 
and cell surface p30. They demonstrated by immunoelectron 
microscopy of cultured embryonic rat brain cells that p30 
was associated with the plasma membrane and intracellu- 
lady with polyribosomes. 
Modulation of P30 Levels in the Transected 
Sciatic Nerve 
Because nerve regeneration in many ways recapitulates the 
process of development (Fawcett and Keynes, 1990), it was 
of interest to examine p30 expression in the injured sciatic 
nerve, a well-characterized model of peripheral nerve regen- 
eration.  The pattern of p30 immunoreactivity of the adult 
sciatic nerve paralleled that of the dorsal root; axons were 
lightly  stained  and  no  staining  of Schwann  cells  was ap- 
parent. However, 2 wk after unilateral nerve transection in 
adult rats, the pattern of immunostaining was dramatically 
changed. Proximal to the cut, the pattern of staining for p30 
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normal and transected sciatic 
nerve shows that p30 immuno- 
reactivity  in  the  transected, 
but not in normal nerve, co- 
localizes with a Sehwann cell 
marker, 217c. 10-#m  cryostat 
sections of normal (a and b) 
and the distal stump of tran- 
sected nerve (c and d)  were 
double labeled with anti-p30 
peptide and 217c. The sections 
were viewed with fluorescein 
optics and rhodamine optics to 
visualize p30  (a and  c)  and 
217c  (b  and  d)  immunore- 
activity, respectively. Arrows 
point  to  some  examples  of 
ceils labeled by both anti-p30 
peptide and 217c. Bar, 20 #m. 
was identical to the normal nerve (Fig. 6 a). However, in the 
distal stump p30 expression was markedly increased. Distal 
to the cut, cells that expressed p30 could be seen in the scar 
(Fig. 6 c) and in the nerve distal to the scar (Fig. 6 e). P30- 
containing cells within the scar had a disordered appearance. 
In contrast, distal to the scar p30 immunoreactivity was in 
a parallel linear array characteristic of the tubes of extracel- 
lular matrix and Schwann cells (bands of Bungner) formed 
in the regenerating nerve prior to regrowth of axons (Dyck 
et al.,  1984). Fig. 6 b, d, andfshow sections, adjacent to 
those in Fig. 6, a, d, and e, respectively, immunostalned with 
an antibody against  S100 that specifically labels  Schwann 
cells in the PNS (Steffansson et al.,  1982). Proximal to the 
point of transection,  anti-p30 peptide and anti-S100 label 
different elements, consistent with the observation that nor- 
mal adult rat Schwann cells do not contain significant levels 
of p30. Distal to the cut, the pattern of staining was similar 
for S100 and p30, suggesting that Schwann cells are the cellu- 
lar elements responsible for the increase in p30 immunoreac- 
tivity seen in  the distal  stump of the regenerating sciatic 
nerve. To confirm this, sections of normal sciatic nerve and 
the distal stump of the transected nerve from the same ani- 
mal were double labeled with anti-p30 peptide and 217c, an 
mAb  specific for Schwann cells in the regenerating nerve 
(Fields and Dammerman,  1985)  which has been shown to 
recognize nerve growth factor receptor (Fiori,  M.  S.,  G. 
Ferrari,  M.  Fabris,  S.  D.  Skaper,  P.  Polato, and Q.  Yan. 
1990.  Soc. Neurosci.  Abstr. 16:826).  The patterns of im- 
munoreactivity for anti-p30  peptide  and  217c  were  very 
different in the normal nerve (Fig. 7, a and b), but they were 
identical in the transected nerve (Fig. 7, c and d). Neurofila- 
merit immunostaining of the severed sciatic nerve showed 
that axons had not yet reentered the distal stump; the front 
of growing axons could be seen at the proximal edge of the 
nerve scar (not shown). 
Modulation of P30 Levels in Schwann Cells by Contact 
with Neurons 
Since Schwann cells deprived of axonal contact by nerve 
transection increased p30 expression in situ, we wondered 
if similar modulation would be observed in vitro. Schwann 
cells were therefore cultured alone or together with purified 
DRG neurons. Schwann cells stained much more darkly for 
p30 when cultured separately than when cocultured with 
DRG neurons.  Additionally, when cocultures of Schwann 
cells and  neurons were immunostained for p30,  Schwann 
cells that were associated with neurites were stained much 
less intensely than Schwann cells on the same coverslip that 
were not in contact with neurons (Fig. 8). The time course 
of this change in p30 expression by Schwann cells was ana- 
lyzed by immunostalning of cocultures in which Schwann 
cells were added to neurons 3 h, 24 h, 2, 5, 10, or 14 d before 
fixation. Downregulation of p30 in Schwann cells was ob- 
served as early as 3 h after the Schwann cells were added to 
neurons, and persisted for the duration of the experiment (2 
wk).  This effect was observed when cells were fixed with 
methanol  before immunostaining,  but  not  when  parafor- 
maidehyde was used as the fixative, suggesting that the differ- 
ences in staining intensity were due to changes in intracellu- 
lar p30 concentration or distribution.  The rapid change in 
p30 expression following cell-cell contact suggests that p30 
responds to or mediates some aspect of  neuron-Schwann cell 
communication.  This change in p30 expression is signifi- 
cantly faster than the downregulation of p30 expression by 
Schwann cells that occurs over several weeks in developing 
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intensely  for p30  when  they  are  not  in  contact  with  neurons. 
Schwann cells  and DRG neurons  were purified  separately (see 
Materials and Methods). Schwann cells were added to the neuron 
cultures and, in this example, incubated together for 24 h. The cells 
were fixed in methanol (5 min,  -20°C) and immunostained using 
10/zg/ml anti-p30 peptide. Schwann cells associated with neurites 
(A) were not stained as intensely as Schwann cells from the same 
coverslip that were not in contact with neurites (B). Bar, 10/zm. 
nerves. This discrepancy between in vivo and in vitro phe- 
nomena raises  the  possibility that  components present in 
nerves can retard down regulation of p30. 
Discussion 
The localization of p30 to both PNS neurons and Schwann 
cells, and its dynamic expression during development dem- 
onstrate that p30  is  present at  the appropriate  times  and 
places to participate in the interactions between neurons and 
Schwann  cells which  lead  to  the  formation of peripheral 
nerves.  Sensory neurons express p30 throughout develop- 
ment and in adult animals.  In contrast, p30 expression in 
Schwann cells is  limited to immature animals  and corre- 
sponds to an active period of PNS morphogenesis in which 
Schwann cells proliferate, modify their spatial relationships 
with growing neurites, and differentiate into ensheathing or 
myelinating glia (Asbury, 1967; Webster et al.,  1973). P30 
expression by Schwann cells is diminished in older animals 
where Schwann cells are differentiated and axon-Schwann 
cell relationships are established and stable. 
Additional evidence suggesting that p30 plays a role in es- 
tablishing neuron-Schwann cell interactions is the observed 
change in p30 expression after peripheral nerve transection. 
The PNS  shows  a unique capacity for regeneration. After 
damage to a peripheral nerve, neuronal processes degener- 
ate, leaving Schwann cells without neuronal contact. After 
injury, Schwann cells modify the expression of a number of 
molecules in a manner consistent with their regulation dur- 
ing development. For example, N-CAM and Ng-CAM are 
expressed in all Schwann cells of the embryonic PNS but 
only in nonmyelinating Schwann cells at later developmental 
times (Faissner et al.,  1984; Nieke and Schachner,  1985). 
N-CAM and Ng-CAM increase in both axons and Schwann 
cells in peripheral nerves following injury and return to nor- 
mal levels after reinnervation (Daniloff et al.,  1986; Jessen 
et al.,  1987).  Other antigens,  such as the myelin-specific 
molecules P0,  MAG,  P1, and P2 that are, conversely, ex- 
pressed at low levels during development and upregulated in 
mature animals,  are downregulated after nerve injury and 
are not reexpressed until regeneration is complete (Willison 
et al.,  1988). There is evidence that reestablishment of nor- 
mal nerve morphology depends on interactions with Schwann 
ceils similar to the cell-cell interactions that occur during 
normal PNS development and that the Schwann cell response 
to injury is important in providing a permissive environment 
for axonal regrowth (Kromer and Cornbrooks, 1985; Smith 
and Stevenson,  1988;  Dusart et al.,  1989). Therefore, up- 
regulation of p30 in Schwann cells of adult rats after nerve 
injury is consistent with a role for p30 in PNS morphogene- 
sis and in PNS repair. 
What is the function of p30 in peripheral nerve develop- 
ment? We have shown that p30 is expressed by most or all 
cells in early embryos, and therefore is expressed by cells 
originating from more than one germ layer. The wide distri- 
bution of p30 during development suggests the possibility 
that p30 functions in cellular processes common to all de- 
veloping organs. Previous work on the heparin-binding mol- 
ecule, p30, suggested that this abundant protein might have 
an adhesive function, since embryonic CNS neurons bind to 
immobilized p30  in  a  dose-dependent,  saturable  manner, 
and binding can be blocked by specific antibodies that recog- 
nize p30.  In  addition,  immobilized p30  promotes neurite 
outgrowth from this  same population of neurons (Rauvala 
and Pihlaskari, 1987). These results and our finding that p30 
expression is increased during PNS pattern formation are 
consistent with the hypothesis that p30 is involved in adhe- 
sion, but do not rule out other possible functions. 
While adhesive molecules are expected to be found on cell 
surfaces and/or in the extracellular matrix, P30 is detectable 
at low levels on the cell surface and at higher levels inside 
cells.  Lactoperoxidase catalyzed  iodination  of live  brain 
cells labeled p30 (Rauvala et al.,  1988), providing evidence 
that p30 is associated with cell surfaces. In addition, Rauvala 
and Pihlaskari (1987)  localized p30 to both the cytoplasm 
and the cell surface of cultured rat embryonic brain cells 
using immunoelectron microscopy. Similarly, while we ob- 
served low levels of p30 immunoreactivity on paraformalde- 
hyde-fixed  and live-stained DRG neurons and Schwann cells, 
immunoreactivity was  significantly  stronger after perme- 
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nol or detergent. 
The finding that brain cells bind to (and extend neurites 
on)  immobilized antibodies recognizing p30  corroborates 
that p30 is present on the surface of ceils and is available for 
binding to ligands (Rauvala et al.,  1988).  If p30 functions 
as an adhesive molecule, the subcellular localization of p30 
predominantly to the cytoplasm was unexpected. However, 
it has been proposed that secreted adhesive molecules might 
mediate adhesive interactions by binding ligands on adjacent 
cells or on a cell and the extracellular matrix (Regen et al., 
1986;  Rutishauser and Jessel,  1988).  Such an activity is 
feasible for p30. P30 inside Schwann cells is downregulated 
by neuronal contact in cell culture, consistent with the possi- 
bility that in response to neuronal contact p30 is secreted 
from Schwann cells and binds to cell surface receptors on 
neurons and/or glial cells, and in this way mediates neu- 
ron-Schwann cell adhesion. While we cannot yet rule out 
that changes in p30 immunoreactivity are due to obscuring 
of immunoreactive epitopes or changes in transcription or 
translation of  p30, the time course of this change is extremely 
rapid, and thus is consistent with p30 secretion by Schwann 
cells. The initial adhesive interaction between neurons and 
Schwann cells has not been accounted for by the activity of 
any known CAM (Rather et al.,  1986;  Bixby et al.,  1988; 
Seilheimer and Schachner, 1988), which leads to the specu- 
lation that p30 may be involved. 
Intracellular p30 released by cell-cell contact and/or other 
cues would become available to bind cells that bear specific 
receptors on their cell surface. Rauvala has proposed that 
p30 is a peripheral membrane protein associated with the 
cell  surface  via  heparin-like  molecules  (Rauvala  et  al., 
1988),  since addition of heparin to cultured brain neurons 
displaced p30  from the cell surface.  The extremely high 
positive charge ratio in the amino terminus of p30 is consis- 
tent with interaction with heparin; the p30 amino terminus 
contains a beparin-binding consensus sequence as defined by 
Cardin and Weintraub (1988).  Cell surface heparan sulfate 
proteoglycans are present on both neurons (Ratner et al., 
1985; Needham et al., 1988) and Schwann cells (Carey and 
Evans, 1989), and are therefore candidate receptors for p30. 
The amino-terminal sequence of p30 is identical to that of 
the broadly distributed DNA-binding protein HMG-1 (Tsuda 
et al., 1988; Wen et al., 1989). Other lines of evidence sug- 
gest that p30 and HMG-1  are similar or identical. HMG-1 
has been shown to have a molecular mass of 28 kD by elec- 
trophoresis, sedimentation coefficient, and amino acid se- 
quencing (Walker et al., 1980); this mass has been confirmed 
by molecular cloning (Tsuda et al., 1988; Wen et al., 1989). 
P30 also migrates with an apparent mobility of ~ 28 kD (see 
Fig. 1, 2, and 4). In addition, Rauvaia (1989) has found that, 
like HMG-1 (Cary et al., 1983), the COOH-terminal of p30 
contains a cluster of  negatively charged amino acids. Finally, 
while HMG-1 was initially purified from calf thymus nuclei 
(Goodwin et al.,  1973)  in a  variety of tissues it has been 
localized predominantly or exclusively to nonnuclear sub- 
cellular fractions, giving rise to the speculation that it is not 
merely being stored for use in the nucleus, but that HMG-1 
may function in cellular processes outside of the nucleus 
(Bustin and Neihart, 1979;  Teng and Teng,  1981; Mosevit- 
sky et ai.,  1989).  While HMG-1  has not previously been 
studied in the PNS, our results suggesting nonnuclear local- 
ization of p30 are consistent with results obtained for HMG- 
1 in the central nervous system. Subcellular fractionation of 
adult brain showed that HMG-1 was not detectable in nuclei 
(Mosevitsky et al.,  1989).  Clarification of the relationship 
between p30 and HMG-1 will not be possible until the com- 
plete sequence of p30 is known. It is important to note that 
both the peptide antibody and the antibody against p30 rec- 
ognize a single band on Western blots and do not recognize 
any material in nuclear fractions (not shown) consistent with 
both the identity of these molecules and the nonnuclear lo- 
calization of HMG-1 in nervous tissue seen in previous stud- 
ies (Mosevitsky et al.,  1989). 
While the relationship between p30 and HMG-1 does not 
preclude an adhesion-related function, it does suggest addi- 
tional or alternative functions. Several functions for nuclear 
HMG-1  have been proposed based on its association with 
DNA. While we have not observed any p30 immunoreactiv- 
ity in nuclei in these studies, it is possible that p30 is in the 
nucleus at concentrations below the limit of detection by im- 
munohistochemistry or that it is modified in the nucleus in 
a  way that masks epitopes recognized by our antibodies. 
HMG-1 may facilitate transcription in a tissue-specific man- 
ner (Eink and Bustin,  1983; Kleinschmidt et al.,  1983).  If 
p30 has the same properties  it could affect expression of 
genes that are important in the neuronal contact-induced 
differentiation of Schwann cells.  HMG-1  levels  and cyto- 
plasmic/nuclear ratios have been shown to change with both 
state of proliferation and differentiation in oviduct and liver 
(Teng and Teng,  1981; Mosevitsky et al., 1989). Our results 
suggest that cellular expression of p30 is regulated during 
changes in the state of differentiation of Schwann cells. The 
regulation of Schwann cell phenotype by contact with axons 
suggests that a novel mechanism of HMG-l-like protein regu- 
lation might be through cell-cell contact. 
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Note Added in  Proof.  We have recently found that an antibody against 
HMG-1/2 obtained from Dr.  Michael Bustin (National Cancer institute, 
NIH) (a) reacts with p30 in Western blot analysis; (b) like anti-p30, stains 
Schwann cells in culture on and off neurites differentially; and (c)  shows 
no nuclear staining of Schwann cells or neurons. 
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